HOME My AAPS
 
Large Text | Regular Text     
Log In.     
  Modified Release Focus Group
 
Section Affiliations

Newsletter

NEW! MRFG Travelships to 2008 AAPS Annual Meeting and Exposition

MRFG Forum Discussion

Archived Webinar: Polymer Nanomaterials for Drug Delivery

2007 MRFG Annual Business Meeting Presentation


The purpose of the Modified Release Focus Group (MRFG) is to provide a forum for scientists - representing academia, industry, and regulatory agencies - involved in the mechanistic understanding, formulation design & development, process development & scale-up, as well as the related regulatory aspects of modified release dosage forms. Modifying the release of a drug from a dosage form is desired to control the physiological site and timing of drug uptake by the body. This focus group will give a forum to exchange ideas and share learnings in the field of modified drug release technology.

Modified release formulation design can be conducted for oral and non-oral administration routes. For an oral dosage form, modification of drug release can be achieved via mechanisms that include drug diffusion, dosage form erosion, osmosis-mediated drug delivery, and others. Particulate, matrix, and coated systems represent a major portion of the oral modified release dosage forms. Modified drug release from dosage forms is complemented by the allied processes of drug design, of dosage administration, and of membrane transport & absorption of drug to the biological site of action; discussion of these phenomena are the subject of other AAPS-sponsored focus groups. The MRFG develops joint programming with these other focus groups to offer members comprehensive coverage of important drug delivery challenges and technologies.

Some of the activities of the Modified Release Focus Group (MRFG) are:
  • Solicit and submit programming ideas related to modified release topics for AAPS annual meetings.
  • Organize educational events such as workshops and symposia, as appropriate.
  • Pose questions or answer those of others' in the MRFG Forum, a chat board for Focus Group members (non-confidential information, only, please).
  • Bring together scientists interested in this area via email distribution lists, newsletters, face to face meeting at the annual meeting, etc.

These activities need member participation, so join the Modified Release Focus Group today, and get your professional colleagues to join, as well. Click here to fill out a Focus Group Membership Form.

As a member, participate in MRFG activities - for instance, join a MRFG Forum discussion to ask a question, start a topic, or share your expertise for the enrichment of others - and learn, share, or serve, as you like.

Follow the MRFG Forum on this website, the Listserv e-mailings, or contact the Chair for information about how MRFG can make you a better informed pharmaceutical scientist.

Questions about the Modified Release Focus Group may be directed to:
Dr. Dave Wallick, Chair
Phone: 989-636-1018


JOIN THE MODIFIED RELEASE FOCUS GROUP

To join the Modified Release Focus Group, click here.

Back To Top

  Leadership

Chair
Joseph P. Reo, Ph.D.
Schering-Plough Corporation
Memphis, TN United States



Chair-Elect
John R. Crison, Ph.D.
Simulations Plus
Lancaster, CA UNITED STATES



Past Chair
Avinash G. Thombre, Ph.D.
Pfizer, Inc.
Groton, CT UNITED STATES




American Association of Pharmaceutical Scientists
2107 Wilson Blvd, Suite 700, Arlington, VA 22201-3042
Main Telephone: 703 243 2800 Main Fax: 703 243 9650
Email: AAPS
View disclaimer
View Privacy Statement
Please email your comments or questions regarding this web site to
Webmaster